​

Funding Round

Series C - Stemirna

Series C - Stemirna

Investment Firm

Overview

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

Announced Date

Jun 03, 2021

Closed on Date

Jun 03, 2021

Funding Type

Series C

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

China Merchants Health

China Merchants Health

No designation

Participant Investors

13

Investor Name
Participant InvestorGreenwoods Investment
Participant InvestorAdvantech Capital
Participant InvestorCITIC Securities
Participant InvestorOrbiMed
Participant InvestorTsing Capital

Round Details and Background

Stemirna raised $187388738 on 2021-06-03 in Series C

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 01, 2017
Angel Round - Stemirna
-undefined
Jun 01, 2018
Seed Round - Stemirna
1-undefined
Feb 01, 2020
Series A - Stemirna
2-4.3M
Sep 01, 2020
Series B - Stemirna
1-undefined

Recent Activity

There is no recent news or activity for this profile.